Cocaine Use Disorder Market
Cocaine use disorder (CUD) is devastating, impacting individuals and society. CUD is the compulsive use of cocaine despite its medical, psychological, and behavioral consequences. It is a severe public health problem, affecting millions of people globally.
Cocaine Use Disorder Epidemiology Insights (2022)
- The Cocaine use disorder 12-month diagnosed prevalent cases in 7MM were ~12.8 million in 2022
- Cocaine use disorder 12-month diagnosed prevalent cases in the United States were ~62% in 2022
- Cocaine use disorder 12-month diagnosed prevalent cases in EU4 and the UK were ~33% in 2022
- Cocaine use disorder 12-month diagnosed prevalent cases in the Japan were ~5% in 2022
Cocaine Use Disorder Epidemiology Segmentation in the 7MM from 2019 to 2032
- 12-month diagnosed prevalent cases
- Gender-specific cases
- Age-specific cases
- Severity-specific cases
Cocaine Use Disorder Market Insight (2022)
Cocaine Use Disorder Market size in the 7MM was ~USD 48.3 million in 2022
Cocaine Use Disorder Emerging Drugs and Key Companies
- STP7 (mavoglurant): STALICLA
- EMB-001: Embera NeuroTherapeutics, and others